Our Q2 2023 earnings report
August 1, 2023
MSD’s Q2 2023 results reflect sustained underlying growth. Our company announced Q2 worldwide sales of $15.0 billion, an increase of 3% from Q2 2022.
“We continue to make great progress as we advance our broad and deep pipeline, raise the bar of innovation, and bring forward leading-edge science to save and improve lives around the world,” said Rob Davis, chairman and chief executive officer, MSD. “We delivered robust underlying growth during the second quarter and are well positioned to achieve strong full-year results. I’m proud of our talented, diverse and dedicated global team that continues to focus on creating value for patients and all our stakeholders now and well into the future.”
MSD anticipates full-year 2023 worldwide sales to be between $58.6 billion and $59.6 billion.
Take a look at the infographic below for more details on Q2 2023 results.